Skip to main content
. Author manuscript; available in PMC: 2019 Jan 2.
Published in final edited form as: Vaccine. 2017 Nov 22;36(1):6–14. doi: 10.1016/j.vaccine.2017.11.027

Table 1.

Hepatitis B vaccine (HepB) schedule and coverage with three doses of hepatitis B vaccine (HepB3)—World Health Organization South-East Asia Region, 2011–2015.

Country HepB schedulea Introduction of HepB (year)b HepB3 coverage per WUENIC (%) [7]
2011 2012 2013 2014 2015
Bangladesh 6, 10, 14 weeks 2005c 96 94 94 94 94
Bhutan Birth, 6, 10, 14 weeks 1996 [7] 95 97 97 99 99
DPR Korea Birth, 6, 10, 14 weeks 2003 [7] 94 96 93 93 96
India Birth, 6, 10, 14 weeks 2012 [16,17] 44 73 70 79 87
Indonesia Birth, 2, 3, 4, 18 months 1997 [14] 81 83 85 81 81
Maldives Birth, 2, 4, 6 months 1993 [7] 96 99 99 99 99
Myanmar 2, 4, 6 months 2003 [7] 40 58 75 75 75
Nepal 6, 10, 14 weeks 2004 [15] 92 90 92 92 91
Sri Lanka 2, 4, 6 months 2003 [7] 99 99 99 99 99
Thailand Birth, 2, 4, 6 months 1992 [13] 98 98 99 99 99
Timor-Leste Birth, 6, 10, 14 weeks 2008 [7] 67 83 82 77 76
SEAR [8] 56 77 76 81 87

HepB: hepatitis B vaccine; HepB3: 3-dose series of Hepatitis B vaccine; SEAR: South-East Asia Region; WUENIC: WHO-UNICEF National Immunization Coverage estimates.

a

Hepatitis B monovalent vaccine is given at birth. All countries use pentavalent vaccine (diphtheria, tetanus, pertussis, Haemophilus influenza type B, and hepatitis B antigens [DTwPHibHepB]) for the 3 dose series except Thailand which uses DTwPHepB (diphtheria, tetanus, pertussis, and hepatitis B antigens).

b

Refers to year of nationwide introduction. Bangladesh, India, Indonesia, Nepal and Thailand had a phased introduction prior to nationwide introduction.

c

Unpublished report.